Início › Câncer de Pulmão de Não Pequenas Células › Illinois › Arlington Heights
Ensaios clínicos de Câncer de Pulmão de Não Pequenas Células em Arlington Heights, IL
12 estudos para Câncer de Pulmão de Não Pequenas Células estão buscando participantes em locais em Arlington Heights e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecrutandoFase 3
- Advocate Good Shepherd Hospital, Barrington · a 9 mi de distância
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
RecrutandoFase 3
- Illinois Cancer Specialists, Arlington Heights
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
RecrutandoFase 3
- Illinois Cancer Specialists, Arlington Heights
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
RecrutandoEstudo observacional
- Northwest Oncology & Hematology, Elk Grove Village · a 6 mi de distância
An External Control Arm Study in Non-Small Cell Lung Cancer
RecrutandoEstudo observacional
- Northwest Oncology and Hematology, Rolling Meadows · a 2 mi de distância
- Northwest Oncology and Hematology, Elk Grove · a 6 mi de distância
- Northwest Oncology and Hematology, Hoffman Estates · a 6 mi de distância
- e mais 1
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
RecrutandoFase 2/3
- Local Institution - 007-883-A, Arlington Heights
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
RecrutandoFase 3
- Illinois Cancer Specialists, Arlington Heights
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
RecrutandoFase 3
- Northwest Oncology & Hematology, Barrington · a 9 mi de distância
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RecrutandoFase 2
- Advocate Good Shepherd Hospital, Barrington · a 9 mi de distância
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
RecrutandoFase 2
- Advocate Good Shepherd Hospital, Barrington · a 9 mi de distância
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RecrutandoFase 2/3
- Advocate Good Shepherd Hospital, Barrington · a 9 mi de distância
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecrutandoEstudo observacional
- Advocate Good Shepherd Hospital, Barrington · a 9 mi de distância
Ensaios de Câncer de Pulmão de Não Pequenas Células em outras cidades
- Houston, TX145 estudos
- New York City, NY121 estudos
- Arlington, VA104 estudos
- Nashville, TN97 estudos
- Boston, MA90 estudos
- Los Angeles, CA87 estudos
- St. Louis, MO73 estudos
- Chicago, IL61 estudos
- Baltimore, MD60 estudos
- San Antonio, TX59 estudos
- Columbus, OH57 estudos
- Washington, DC55 estudos
Outros estudos em Arlington Heights
- Câncer Colorretal12 estudos
- Câncer de Pulmão9 estudos
- Câncer de Mama7 estudos
- Insuficiência Cardíaca7 estudos
- Câncer Metastático6 estudos
- Colite ulcerativa6 estudos
- Câncer de Cólon6 estudos
- Câncer de Ovário5 estudos
- Obesidade5 estudos
- Sobrepeso5 estudos
- Câncer de Próstata3 estudos
- Condições de Pele3 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.